Johnson & Johnson said on Tuesday it would suspend the supply of its personal care products in Russia, adding it would continue to supply medicines and medical devices in the region.
The company, along with several other drugmakers such as Eli Lilly and Co and Pfizer, said earlier this month it would stop enrollment in clinical trials in Russia.
J&J had said it was stopping enrollment in Ukraine and Belarus as well as new site openings, but was committed to providing essential health products, U.S. News reports.
